Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Starling Oncology Inc., 3 years.
Starling Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 2026 | Starling Oncology Inc. | Grant or award | +30,120 | — | — |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +46,296 | — | — |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +35,494 | — | — |
| Nov 18, 2025 | Starling Oncology Inc. | Open-market sale | −2,160 | $4.00 | $8,640 |
| Nov 18, 2025 | Starling Oncology Inc. | Open-market sale | −1,210 | $4.00 | $4,840 |
| Nov 18, 2025 | Starling Oncology Inc. | Open-market sale | −46,630 | $4.00 | $186,520 |
| Mar 26, 2025 | Starling Oncology Inc. | Open-market purchase | +90,562 | $1.04 | $94,184 |
| Nov 22, 2024 | Starling Oncology Inc. | Grant or award | +50,000 | — | — |
| Nov 12, 2024 | Starling Oncology Inc. | Other | −20,248 | — | — |
| Nov 12, 2024 | Starling Oncology Inc. | Other | −30,372 | — | — |
| Dec 26, 2023 | Starling Oncology Inc. | Grant or award | +46,630 | — | — |
| Mar 17, 2023 | Starling Oncology Inc. | Grant or award | +6,562 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.